 SALT LAKE CITY, July 28, 2022 GLOBE NEWSWIRE -- Myriad Genetics, Inc., NASDAQ: MYGN, a leader in genetic testing and precision medicine, will hold its second-quarter earnings conference call on Thursday, Aug. 4, 2022 at 4:30 p.m. EDT. The companys quarterly earnings will be released the same day prior to the market opening. 